Insider Transactions in Q4 2025 at Alignment Healthcare, Inc. (ALHC)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2025
|
Robert L. Scavo Chief Information Officer |
SELL
Open market or private sale
|
Direct |
69,541
-6.12%
|
$1,321,279
$19.04 P/Share
|
|
Dec 29
2025
|
Hyong Kim Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
12,694
-1.76%
|
$241,186
$19.04 P/Share
|
|
Dec 29
2025
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
605,648
-10.81%
|
$11,507,312
$19.04 P/Share
|
|
Dec 29
2025
|
Dawn Christine Maroney President |
SELL
Open market or private sale
|
Direct |
282,070
-8.55%
|
$5,359,330
$19.04 P/Share
|
|
Dec 29
2025
|
Christopher J Joyce Chief Legal and Admin. Officer |
SELL
Open market or private sale
|
Direct |
16,187
-2.51%
|
$307,553
$19.04 P/Share
|
|
Dec 15
2025
|
Dawn Christine Maroney President |
SELL
Open market or private sale
|
Direct |
113,319
-6.36%
|
$2,266,380
$20.01 P/Share
|
|
Dec 12
2025
|
Dawn Christine Maroney President |
SELL
Open market or private sale
|
Direct |
16,681
-0.93%
|
$333,620
$20.02 P/Share
|
|
Dec 12
2025
|
General Atlantic LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
11,119,494
-45.21%
|
$200,150,892
$18.57 P/Share
|
|
Dec 12
2025
|
General Atlantic (Aln Hlth), L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
11,119,494
-45.21%
|
$200,150,892
$18.57 P/Share
|
|
Dec 10
2025
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
180,000
-7.12%
|
$3,420,000
$19.02 P/Share
|
|
Dec 10
2025
|
Sebastian Burzacchi COO - Mgmt Services Org |
SELL
Open market or private sale
|
Direct |
12,585
-5.03%
|
$239,115
$19.26 P/Share
|
|
Dec 08
2025
|
Christopher J Joyce Chief Legal and Admin. Officer |
SELL
Open market or private sale
|
Direct |
19,706
-5.74%
|
$374,414
$19.33 P/Share
|
|
Nov 25
2025
|
Joseph S Konowiecki Director |
SELL
Open market or private sale
|
Direct |
25,000
-2.31%
|
$475,000
$19.0 P/Share
|
|
Nov 11
2025
|
Joseph S Konowiecki Director |
SELL
Open market or private sale
|
Direct |
4,832
-0.44%
|
$77,312
$16.49 P/Share
|
|
Nov 10
2025
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
180,000
-6.65%
|
$2,880,000
$16.32 P/Share
|
|
Oct 28
2025
|
Joseph S Konowiecki Director |
SELL
Open market or private sale
|
Direct |
25,000
-2.25%
|
$450,000
$18.0 P/Share
|
|
Oct 10
2025
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
180,000
-6.24%
|
$3,060,000
$17.29 P/Share
|
|
Oct 09
2025
|
Hyong Kim Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
51,379
-12.42%
|
$873,443
$17.57 P/Share
|
|
Oct 08
2025
|
Hyong Kim Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
33,655
-7.52%
|
$572,135
$17.29 P/Share
|